S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Albany Park Relaunches With Seven-Day Custom Sofa Production

Most furniture retailers rely on third-party factories, but Albany Park is breaking the mold by bringing production in-house. Following a corporate relaunch, the brand now manufactures every piece to order at its facility in El Florido, Mexico, promising delivery within seven days of a customer placing their order.

Albany Park Relaunches With Seven-Day Custom Sofa Production
Photo: Bio & News

The strategy centers on the Kova modular line, which allows buyers to select their preferred level of cushion support—soft, medium, or firm. If the choice misses the mark, the company dispatches a technician to perform a free cushion exchange in the customer’s home within 60 days of delivery. This flexibility is supported by parent company Exemplis, a manufacturer with three decades of experience supplying office and institutional furniture using a workforce of over 2,000 craftspeople.

CEO Paul DeVries claims the model eliminates the long-standing industry trade-off between off-the-shelf speed and custom-made quality. Beyond production, the brand is enforcing a new pricing structure designed to curb the cycle of perpetual markdowns. By capping discounts at 25 percent during limited events, the company aims to maintain transparent pricing. This direct-to-consumer approach covers the entire manufacturing lifecycle, from frame construction and upholstery to final quality inspection before shipping.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!